ABCELLERA BIOLOGICS (8QQ) — Free Cash Flow Generation Index
ABCELLERA BIOLOGICS (8QQ) has a Free Cash Flow Generation Index of 0.92x as of June 2026. Free cash flow of €23.79 Million represents 1% of operating cash flow (€25.92 Million). Explore capital reinvestment ratio of ABCELLERA BIOLOGICS to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
ABCELLERA BIOLOGICS Free Cash Flow Generation Index (2021–2022)
Historical FCF Generation Index trend for ABCELLERA BIOLOGICS across 2 annual periods. For the full cash flow conversion analysis, see 8QQ operating cash flow.
Annual Free Cash Flow Generation for ABCELLERA BIOLOGICS (2021–2022)
Year-by-year Free Cash Flow Generation Index for ABCELLERA BIOLOGICS. Check ABCELLERA BIOLOGICS cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.74x | €204.70 Million | €277.36 Million | €72.66 Million | ▼ -3.0% |
| 2021 | 0.76x | €186.13 Million | €244.58 Million | €58.45 Million | — |